SENORES
NSESenores Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,417.80
1.90 (0.13%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹6.53K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
53.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹575.65+146.3%
52W High₹1,487.9-4.7%
Current Price
₹1,417.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,134.24
Upper Circuit₹1,701.36
Reference Price
₹1,417.80
Investment Checklist
Bull Flag on 1D — target ₹1484.3
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
RSI at 72.9 — overbought, pullback risk
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
83%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1311.9
EMA50
1177.08
EMA200
924.02
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows7
Lower Highs4
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹1360.00
₹1253.70
₹1194.40
₹1173.80
₹1001.00
Volume Analysis
TrendDECREASING
Change-26.30%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹1403.62
3% Risk₹1375.27
5% Risk₹1346.91
7% Risk (Custom)
₹1318.55Technical Levels
1x ATR (Volatility)₹1356.94
2x ATR (Swing)₹1296.08
3x ATR (Trend)₹1235.22
Immediate Support₹1360.00
Moving Averages
EMA 9 (Short-term)₹1373.46
EMA 20 (Medium-term)₹1311.90
EMA 50 (Trend)₹1177.08
EMA 200 (Long-term)₹924.02
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹98.8 Cr | ₹130.3 Cr | ₹153.4 Cr | ₹164.9 Cr |
| Net Profit | ₹17.8 Cr | ₹19.7 Cr | ₹32.4 Cr | ₹31.7 Cr |
| EPS | — | ₹4.60 | ₹6.54 | ₹7.29 |
| Operating Profit | ₹30 Cr | ₹37.5 Cr | ₹54.9 Cr | ₹57.8 Cr |
ROE
7.45%
ROCE
8.26%
Debt/Equity
0.40
Current Ratio
3.00
OPM
35.06%
NPM
19.21%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Senores Pharmaceuticals Limited | ₹1,417.80 | -0.13% | 53.8 | ₹6.53K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SENORES
View All
negative
CNBC TV18 - Markets 57d ago
Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness
Senores Pharmaceuticals shares fell over 5% despite strong year-on-year earnings growth, as investors reacted to sequential weakness in EBITDA and margins amid a softer operational performance in the March quarter.
MOGSECSENORESFinancial ServicesHealthcare
positive
Moneycontrol NaNd ago
Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities
Choice Institutional Equities is bullish on Senores Pharma has recommended buy rating on the stock with a target price of Rs 1640 in its research report dated July 08, 2026.
CHOICEINSENORESSPARCFinancial ServicesHealthcare